1887
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.

Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Buy this Microbiology Spectrum Article
Price Non-Member $15.00
  • Authors: Ryan G. Gaudet1, Clinton J. Bradfield4, John D. MacMicking7
  • Editor: Siamon Gordon10
  • VIEW AFFILIATIONS HIDE AFFILIATIONS
    Affiliations: 1: Howard Hughes Medical Institute, Chevy Chase, MD 20815; 2: Yale Systems Biology Institute; 3: Departments of Microbial Pathogenesis and Immunobiology, Yale University School of Medicine, New Haven, CT 06520; 4: Howard Hughes Medical Institute, Chevy Chase, MD 20815; 5: Yale Systems Biology Institute; 6: Departments of Microbial Pathogenesis and Immunobiology, Yale University School of Medicine, New Haven, CT 06520; 7: Howard Hughes Medical Institute, Chevy Chase, MD 20815; 8: Yale Systems Biology Institute; 9: Departments of Microbial Pathogenesis and Immunobiology, Yale University School of Medicine, New Haven, CT 06520; 10: Oxford University, Oxford, United Kingdom
  • Source: microbiolspec December 2016 vol. 4 no. 6 doi:10.1128/microbiolspec.MCHD-0050-2016
  • Received 17 September 2016 Accepted 20 October 2016 Published 16 December 2016
  • John D. MacMicking, john.macmicking@yale.edu
image of Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells
    Preview this microbiology spectrum article:
    Zoom in
    Zoomout

    Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells, Page 1 of 2

    | /docserver/preview/fulltext/microbiolspec/4/6/MCHD-0050-2016-1.gif /docserver/preview/fulltext/microbiolspec/4/6/MCHD-0050-2016-2.gif
  • Abstract:

    Specialized adaptations for killing microbes are synonymous with phagocytic cells including macrophages, monocytes, inflammatory neutrophils, and eosinophils. Recent genome sequencing of extant species, however, reveals that analogous antimicrobial machineries exist in certain non-immune cells and also within species that ostensibly lack a well-defined immune system. Here we probe the evolutionary record for clues about the ancient and diverse phylogenetic origins of macrophage killing mechanisms and how some of their properties are shared with cells outside the traditional bounds of immunity in higher vertebrates such as mammals.

  • Citation: Gaudet R, Bradfield C, MacMicking J. 2016. Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells. Microbiol Spectrum 4(6):MCHD-0050-2016. doi:10.1128/microbiolspec.MCHD-0050-2016.

Key Concept Ranking

Bacterial Proteins
0.6051729
Adaptive Immune System
0.58754325
Viruses
0.5460862
Hepatitis C virus
0.4897893
0.6051729

References

1. Randow F, MacMicking JD, James LC. 2013. Cellular self-defense: how cell-autonomous immunity protects against pathogens. Science 340:701–706. [PubMed]
2. Tauber AI. 2003. Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol 4:897–901. [PubMed] [PubMed]
3. Stuart LM, Ezekowitz RA. 2005. Phagocytosis: elegant complexity. Immunity 22:539–550.
4. Buchmann K. 2014. Evolution of innate immunity: clues from invertebrates via fish to mammals. Front Immunol 5:459. doi:10.3389/fimmu.2014.00459. [PubMed]
5. MacMicking JD. 2009. Recognizing macrophage activation and host defense. Cell Host Microbe 5:405–407. [PubMed]
6. MacMicking JD. 2012. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 12:367–382. [PubMed]
7. MacMicking J, Xie QW, Nathan C. 1997. Nitric oxide and macrophage function. Annu Rev Immunol 15:323–350. [PubMed]
8. McGettigan J, McLennan RK, Broderick KE, Kean L, Allan AK, Cabrero P, Regulski MR, Pollock VP, Gould GW, Davies SA, Dow JA. 2005. Insect renal tubules constitute a cell-autonomous immune system that protects the organism against bacterial infection. Insect Biochem Mol Biol 35:741–754. [PubMed]
9. Palumbo A. 2005. Nitric oxide in marine invertebrates: a comparative perspective. Comp Biochem Physiol A Mol Integr Physiol 142:241–248. [PubMed]
10. Gusarov I, Shatalin K, Starodubtseva M, Nudler E. 2009. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325:1380–1384. [PubMed]
11. Baldauf SL, Doolittle WF. 1997. Origin and evolution of the slime molds (Mycetozoa). Proc Natl Acad Sci U S A 94:12007–12012. [PubMed]
12. Bapteste E, Brinkmann H, Lee JA, Moore DV, Sensen CW, Gordon P, Duruflé L, Gaasterland T, Lopez P, Müller M, Philippe H. 2002. The analysis of 100 genes supports the grouping of three highly divergent amoebae: Dictyostelium, Entamoeba, and Mastigamoeba. Proc Natl Acad Sci U S A 99:1414–1419. [PubMed]
13. Song J, Xu Q, Olsen R, Loomis WF, Shaulsky G, Kuspa A, Sucgang R. 2005. Comparing the Dictyostelium and Entamoeba genomes reveals an ancient split in the Conosa lineage. PLoS Comput Biol 1:e71. doi:10.1371/journal.pcbi.0010071. [PubMed]
14. Bozzaro S, Bucci C, Steinert M. 2008. Phagocytosis and host-pathogen interactions in Dictyostelium with a look at macrophages. Int Rev Cell Mol Biol 271:253–300. [PubMed]
15. Minakami R, Sumimotoa H. 2006. Phagocytosis-coupled activation of the superoxide-producing phagocyte oxidase, a member of the NADPH oxidase (Nox) family. Int J Hematol 84:193–198. [PubMed]
16. Yan L, Cerny RL, Cirillo JD. 2004. Evidence that hsp90 is involved in the altered interactions of Acanthamoeba castellanii variants with bacteria. Eukaryot Cell 3:567–578. [PubMed]
17. Lardy B, Bof M, Aubry L, Paclet MH, Morel F, Satre M, Klein G. 2005. NADPH oxidase homologs are required for normal cell differentiation and morphogenesis in Dictyostelium discoideum. Biochim Biophys Acta 1744:199–212. [PubMed]
18. Rodriguez-Paris JM, Nolta KV, Steck TL. 1993. Characterization of lysosomes isolated from Dictyostelium discoideum by magnetic fractionation. J Biol Chem 268:9110–9116. [PubMed]
19. Souza GM, Mehta DP, Lammertz M, Rodriguez-Paris J, Wu R, Cardelli JA, Freeze HH. 1997. Dictyostelium lysosomal proteins with different sugar modifications sort to functionally distinct compartments. J Cell Sci 110:2239–2248. [PubMed]
20. Gotthardt D, Warnatz HJ, Henschel O, Brückert F, Schleicher M, Soldati T. 2002. High-resolution dissection of phagosome maturation reveals distinct membrane trafficking phases. Mol Biol Cell 13:3508–3520. [PubMed]
21. Leippe M, Bruhn H, Hecht O, Grötzinger J. 2005. Ancient weapons: the three-dimensional structure of amoebapore A. Trends Parasitol 21:5–7. [PubMed]
22. Leippe M. 1995. Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite. Cell 83:17–18. [PubMed]
23. Leippe M. 1999. Antimicrobial and cytolytic polypeptides of amoeboid protozoa—effector molecules of primitive phagocytes. Dev Comp Immunol 23:267–279. [PubMed]
24. Courville P, Chaloupka R, Cellier MFM. 2006. Recent progress in structure-function analyses of Nramp proton-dependent metal-ion transporters. Biochem Cell Biol 84:960–978. [PubMed]
25. Forbes JR, Gros P. 2001. Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol 9:397–403. [PubMed]
26. Nevo Y, Nelson N. 2006. The NRAMP family of metal-ion transporters. Biochim Biophys Acta 1763:609–620. [PubMed]
27. Cellier MF. 2012. Nutritional immunity: homology modeling of Nramp metal import. Adv Exp Med Biol 946:335–351. [PubMed]
28. Richer E, Courville P, Bergevin I, Cellier MFM. 2003. Horizontal gene transfer of “prototype” Nramp in bacteria. J Mol Evol 57:363–376. [PubMed]
29. Peracino B, Wagner C, Balest A, Balbo A, Pergolizzi B, Noegel AA, Steinert M, Bozzaro S. 2006. Function and mechanism of action of Dictyostelium Nramp1 (Slc11a1) in bacterial infection. Traffic 7:22–38. [PubMed]
30. Peracino B, Buracco S, Bozzaro S. 2013. The Nramp (Slc11) proteins regulate development, resistance to pathogenic bacteria and iron homeostasis in Dictyostelium discoideum. J Cell Sci 126:301–311. [PubMed]
31. Appelberg R. 2006. Macrophage nutriprive antimicrobial mechanisms. J Leukoc Biol 79:1117–1128. [PubMed]
32. Schaap P. 2007. Evolution of size and pattern in the social amoebas. BioEssays 29:635–644. [PubMed]
33. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20:197–216. [PubMed]
34. Chen G, Zhuchenko O, Kuspa A. 2007. Immune-like phagocyte activity in the social amoeba. Science 317:678–681. [PubMed]
35. Zhang X, Zhuchenko O, Kuspa A, Soldati T. 2016. Social amoebae trap and kill bacteria by casting DNA nets. Nat Commun 7:10938. doi:10.1038/ncomms10938. [PubMed]
36. Dzik JM. 2010. The ancestry and cumulative evolution of immune reactions. Acta Biochim Pol 57:443–466. [PubMed]
37. Salazar-Jaramillo L, Paspati A, van de Zande L, Vermeulen CJ, Schwander T, Wertheim B. 2014. Evolution of a cellular immune response in Drosophila: a phenotypic and genomic comparative analysis. Genome Biol Evol 6:273–289. [PubMed]
38. Rhodes CP, Ratcliffe NA, Rowley AF. 1982. Presence of coelomocytes in the primitive chordate amphioxus (Branchiostoma lanceolatum). Science 217:263–265. [PubMed]
39. Ribatti D, Crivellato E. 2014. Mast cell ontogeny: an historical overview. Immunol Lett 159:11–14. [PubMed]
40. Lemaitre B, Hoffmann J. 2007. The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697–743. [PubMed]
41. Clayton AM, Dong Y, Dimopoulos G. 2014. The Anopheles innate immune system in the defense against malaria infection. J Innate Immun 6:169–181. [PubMed]
42. Andrä J, Herbst R, Leippe M. 2003. Amoebapores, archaic effector peptides of protozoan origin, are discharged into phagosomes and kill bacteria by permeabilizing their membranes. Dev Comp Immunol 27:291–304. [PubMed]
43. Mallo GV, Kurz CL, Couillault C, Pujol N, Granjeaud S, Kohara Y, Ewbank JJ. 2002. Inducible antibacterial defense system in C. elegans. Curr Biol 12:1209–1214. [PubMed]
44. Lemaitre B, Reichhart JM, Hoffmann JA. 1997. Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc Natl Acad Sci U S A 94:14614–14619. [PubMed]
45. Salzet M, Tasiemski A, Cooper E. 2006. Innate immunity in lophotrochozoans: the annelids. Curr Pharm Des 12:3043–3050. [PubMed]
46. Hoffmann J. 2007. Antifungal defense in Drosophila. Nat Immunol 8:543–545. [PubMed]
47. Cox RL, Mariano T, Heck DE, Laskin JD, Stegeman JJ. 2001. Nitric oxide synthase sequences in the marine fish Stenotomus chrysops and the sea urchin Arbacia punctulata, and phylogenetic analysis of nitric oxide synthase calmodulin-binding domains. Comp Biochem Physiol B Biochem Mol Biol 130:479–491.
48. Luckhart S, Rosenberg R. 1999. Gene structure and polymorphism of an invertebrate nitric oxide synthase gene. Gene 232:25–34. [PubMed]
49. Giovine M, Pozzolini M, Favre A, Bavestrello G, Cerrano C, Ottaviani F, Chiarantini L, Cerasi A, Cangiotti M, Zocchi E, Scarfì S, Sarà M, Benatti U. 2001. Heat stress-activated, calcium-dependent nitric oxide synthase in sponges. Nitric Oxide 5:427–431. [PubMed]
50. Ottaviani E, Paeman LR, Cadet P, Stefano GB. 1993. Evidence for nitric oxide production and utilization as a bacteriocidal agent by invertebrate immunocytes. Eur J Pharmacol 248:319–324. [PubMed]
51. Franchini A, Conte A, Ottaviani E. 1995. Nitric oxide: an ancestral immunocyte effector molecule. Adv Neuroimmunol 5:463–478. [PubMed]
52. Foley E, O’Farrell PH. 2003. Nitric oxide contributes to induction of innate immune responses to gram-negative bacteria in Drosophila. Genes Dev 17:115–125. [PubMed]
53. Babior BM, Kipnes RS, Curnutte JT. 1973. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741–744. [PubMed]
54. Whitten MM, Ratcliffe NA. 1999. In vitro superoxide activity in the haemolymph of the West Indian leaf cockroach, Blaberus discoidalis. J Insect Physiol 45:667–675. [PubMed]
55. García-García E, Prado-Alvarez M, Novoa B, Figueras A, Rosales C. 2008. Immune responses of mussel hemocyte subpopulations are differentially regulated by enzymes of the PI 3-K, PKC, and ERK kinase families. Dev Comp Immunol 32:637–653. [PubMed]
56. Peskin AV, Labas YA, Tikhonov AN. 1998. Superoxide radical production by sponges Sycon sp. FEBS Lett 434:201–204. [PubMed]
57. Babior BM. 1999. NADPH oxidase: an update. Blood 93:1464–1476. [PubMed]
58. Sumimoto H. 2008. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 275:3249–3277. [PubMed]
59. Andreakis N, D’Aniello S, Albalat R, Patti FP, Garcia-Fernàndez J, Procaccini G, Sordino P, Palumbo A. 2011. Evolution of the nitric oxide synthase family in metazoans. Mol Biol Evol 28:163–179. [PubMed]
60. Ritsick DR, Edens WA, McCoy JW, Lambeth JD. 2004. The use of model systems to study biological functions of Nox/Duox enzymes. Biochem Soc Symp 71:85–96. [PubMed]
61. Lee KA, Kim SH, Kim EK, Ha EM, You H, Kim B, Kim MJ, Kwon Y, Ryu JH, Lee WJ. 2013. Bacterial-derived uracil as a modulator of mucosal immunity and gut-microbe homeostasis in Drosophila. Cell 153:797–811. [PubMed]
62. Ha EM, Oh CT, Bae YS, Lee WJ. 2005. A direct role for dual oxidase in Drosophila gut immunity. Science 310:847–850. [PubMed]
63. Geiszt M, Witta J, Baffi J, Lekstrom K, Leto TL. 2003. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 17:1502–1504.
64. El Hassani RA, Benfares N, Caillou B, Talbot M, Sabourin J-C, Belotte V, Morand S, Gnidehou S, Agnandji D, Ohayon R, Kaniewski J, Noël-Hudson MS, Bidart JM, Schlumberger M, Virion A, Dupuy C. 2005. Dual oxidase2 is expressed all along the digestive tract. Am J Physiol Gastrointest Liver Physiol 288:G933–G942. [PubMed]
65. Kounatidis I, Ligoxygakis P. 2012. Drosophila as a model system to unravel the layers of innate immunity to infection. Open Biol 2:120075. doi:10.1098/rsob.120075. [PubMed]
66. Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M. 2003. Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides 24:1655–1667. [PubMed]
67. Gennaro R, Zanetti M. 2000. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55:31–49. [PubMed]
68. Bals R, Wilson JM. 2003. Cathelicidins—a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 60:711–720. [PubMed]
69. Cole AM, Shi J, Ceccarelli A, Kim YH, Park A, Ganz T. 2001. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97:297–304. [PubMed]
70. Toni M, De Angelis F, di Patti MC, Cioni C. 2015. Nitric oxide synthase in the central nervous system and peripheral organs of Stramonita haemastoma: protein distribution and gene expression in response to thermal stress. Mar Drugs 13:6636–6664. [PubMed]
71. Chettri JK, Raida MK, Kania PW, Buchmann K. 2012. Differential immune response of rainbow trout (Oncorhynchus mykiss) at early developmental stages (larvae and fry) against the bacterial pathogen Yersinia ruckeri. Dev Comp Immunol 36:463–474. [PubMed]
72. Grayson TH, Cooper LF, Wrathmell AB, Roper J, Evenden AJ, Gilpin ML. 2002. Host responses to Renibacterium salmoninarum and specific components of the pathogen reveal the mechanisms of immune suppression and activation. Immunology 106:273–283. [PubMed]
73. Fast MD, Tse B, Boyd JM, Johnson SC. 2009. Mutations in the Aeromonas salmonicida subsp. salmonicida type III secretion system affect Atlantic salmon leucocyte activation and downstream immune responses. Fish Shellfish Immunol 27:721–728. [PubMed]
74. Grayfer L, Hodgkinson JW, Belosevic M. 2014. Antimicrobial responses of teleost phagocytes and innate immune evasion strategies of intracellular bacteria. Dev Comp Immunol 43:223–242. [PubMed]
75. Blackwell JM, Goswami T, Evans CA, Sibthorpe D, Papo N, White JK, Searle S, Miller EN, Peacock CS, Mohammed H, Ibrahim M. 2001. SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol 3:773–784. [PubMed]
76. Alter-Koltunoff M, Goren S, Nousbeck J, Feng CG, Sher A, Ozato K, Azriel A, Levi BZ. 2008. Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc. J Biol Chem 283:2724–2733. [PubMed]
77. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093. [PubMed]
78. Douglas SE, Gallant JW, Liebscher RS, Dacanay A, Tsoi SC. 2003. Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish. Dev Comp Immunol 27:589–601. [PubMed]
79. Costa MM, Maehr T, Diaz-Rosales P, Secombes CJ, Wang T. 2011. Bioactivity studies of rainbow trout (Oncorhynchus mykiss) interleukin-6: effects on macrophage growth and antimicrobial peptide gene expression. Mol Immunol 48:1903–1916. [PubMed]
80. Taylor MW, Feng GS. 1991. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516–2522. [PubMed]
81. Adams O, Besken K, Oberdörfer C, MacKenzie CR, Rüssing D, Däubener W. 2004. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect 6:806–812. [PubMed]
82. Obojes K, Andres O, Kim KS, Däubener W, Schneider-Schaulies J. 2005. Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J Virol 79:7768–7776. [PubMed]
83. Bodaghi B, Goureau O, Zipeto D, Laurent L, Virelizier JL, Michelson S. 1999. Role of IFN-γ-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J Immunol 162:957–964. [PubMed]
84. Niño-Castro A, Abdullah Z, Popov A, Thabet Y, Beyer M, Knolle P, Domann E, Chakraborty T, Schmidt SV, Schultze JL. 2014. The IDO1-induced kynurenines play a major role in the antimicrobial effect of human myeloid cells against Listeria monocytogenes. Innate Immun 20:401–411. [PubMed]
85. Yuasa HJ, Takubo M, Takahashi A, Hasegawa T, Noma H, Suzuki T. 2007. Evolution of vertebrate indoleamine 2,3-dioxygenases. J Mol Evol 65:705–714. [PubMed]
86. Ball HJ, Jusof FF, Bakmiwewa SM, Hunt NH, Yuasa HJ. 2014. Tryptophan-catabolizing enzymes—party of three. Front Immunol 5:485. doi:10.3389/fimmu.2014.00485.
87. Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, Ahlin A, Nemet K, Hossle JP, Bernatowska-Matuszkiewicz E, Middleton-Price H. 1996. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87:1663–1681. [PubMed]
88. Heyworth PG, Cross AR, Curnutte JT. 2003. Chronic granulomatous disease. Curr Opin Immunol 15:578–584. [PubMed]
89. Shiloh MU, MacMicking JD, Nicholson S, Brause JE, Potter S, Marino M, Fang F, Dinauer M, Nathan C. 1999. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10:29–38. [PubMed]
90. Bedard K, Krause K-H. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313. [PubMed]
91. Pacquelet S, Lehmann M, Luxen S, Regazzoni K, Frausto M, Noack D, Knaus UG. 2008. Inhibitory action of NoxA1 on dual oxidase activity in airway cells. J Biol Chem 283:24649–24658. [PubMed]
92. Grasberger H, Refetoff S. 2006. Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J Biol Chem 281:18269–18272. [PubMed]
93. Wink DA, Hines HB, Cheng RYS, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA. 2011. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol 89:873–891. [PubMed]
94. Nathan C, Xie QW. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915–918. [PubMed]
95. Denicola A, Rubbo H, Rodríguez D, Radi R. 1993. Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Biochem Biophys 304:279–286. [PubMed]
96. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 167:1358–1363. [PubMed]
97. De Duve C, Wattiaux R. 1966. Functions of lysosomes. Annu Rev Physiol 28:435–492. [PubMed]
98. Ohkuma S, Poole B. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A 75:3327–3331. [PubMed]
99. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299:1400–1403. [PubMed]
100. Jancic C, Savina A, Wasmeier C, Tolmachova T, El-Benna J, Dang PM, Pascolo S, Gougerot-Pocidalo MA, Raposo G, Seabra MC, Amigorena S. 2007. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol 9:367–378. [PubMed]
101. MacMicking JD, Taylor GA, McKinney JD. 2003. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302:654–659. [PubMed]
102. Vandal OH, Pierini LM, Schnappinger D, Nathan CF, Ehrt S. 2008. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat Med 14:849–854. [PubMed]
103. Lübke T, Lobel P, Sleat DE. 2009. Proteomics of the lysosome. Biochim Biophys Acta 1793:625–635. [PubMed]
104. Schröder BA, Wrocklage C, Hasilik A, Saftig P. 2010. The proteome of lysosomes. Proteomics 10:4053–4076. [PubMed]
105. Weiss G, Schaible UE. 2015. Macrophage defense mechanisms against intracellular bacteria. Immunol Rev 264:182–203. [PubMed]
106. Santic M, Molmeret M, Abu Kwaik Y. 2005. Maturation of the Legionella pneumophila-containing phagosome into a phagolysosome within gamma interferon-activated macrophages. Infect Immun 73:3166–3171. [PubMed]
107. Ishibashi Y, Arai T. 1990. Effect of γ-interferon on phagosome-lysosome fusion in Salmonella typhimurium-infected murine macrophages. FEMS Microbiol Immunol 2:75–82. [PubMed]
108. Jutras I, Houde M, Currier N, Boulais J, Duclos S, LaBoissière S, Bonneil E, Kearney P, Thibault P, Paramithiotis E, Hugo P, Desjardins M. 2008. Modulation of the phagosome proteome by interferon-γ. Mol Cell Proteomics 7:697–715. [PubMed]
109. Tsukada M, Ohsumi Y. 1993. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 333:169–174. [PubMed]
110. Klionsky DJ, Cregg JM, Dunn WA, Jr, Emr SD, Sakai Y, Sandoval IV, Sibirny A, Subramani S, Thumm M, Veenhuis M, Ohsumi Y. 2003. A unified nomenclature for yeast autophagy-related genes. Dev Cell 5:539–545. [PubMed]
111. Klionsky DJ, Cueva R, Yaver DS. 1992. Aminopeptidase I of Saccharomyces cerevisiae is localized to the vacuole independent of the secretory pathway. J Cell Biol 119:287–299. [PubMed]
112. Deretic V. 2011. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev 240:92–104. [PubMed]
113. Levine B, Klionsky DJ. 2004. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6:463–477. [PubMed]
114. Levine B. 2005. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 120:159–162. [PubMed]
115. Deshaies RJ, Joazeiro CAP. 2009. RING domain E3 ubiquitin ligases. Annu Rev Biochem 78:399–434. [PubMed]
116. Thurston TLM, Wandel MP, von Muhlinen N, Foeglein A, Randow F. 2012. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482:414–418. [PubMed]
117. Zhang J, Tripathi DN, Jing J, Alexander A, Kim J, Powell RT, Dere R, Tait-Mulder J, Lee JH, Paull TT, Pandita RK, Charaka VK, Pandita TK, Kastan MB, Walker CL. 2015. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat Cell Biol 17:1259–1269. [PubMed]
118. Narendra D, Tanaka A, Suen D-F, Youle RJ. 2009. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 5:706–708. [PubMed]
119. Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsuchiya H, Yoshihara H, Hirokawa T, Endo T, Fon EA, Trempe JF, Saeki Y, Tanaka K, Matsuda N. 2014. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510:162–166. [PubMed]
120. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, Dötsch V, Bumann D, Dikic I. 2011. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333:228–233. [PubMed]
121. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkøy G, Johansen T. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131–24145. [PubMed]
122. Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F. 2009. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 10:1215–1221. [PubMed]
123. Kirkin V, Lamark T, Sou YS, Bjørkøy G, Nunn JL, Bruun JA, Shvets E, McEwan DG, Clausen TH, Wild P, Bilusic I, Theurillat JP, Øvervatn A, Ishii T, Elazar Z, Komatsu M, Dikic I, Johansen T. 2009. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 33:505–516. [PubMed]
124. Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N. 2011. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 44:279–289. [PubMed]
125. Mostowy S, Sancho-Shimizu V, Hamon MA, Simeone R, Brosch R, Johansen T, Cossart P. 2011. p62 and NDP52 proteins target intracytosolic Shigella and Listeria to different autophagy pathways. J Biol Chem 286:26987–26995. [PubMed]
126. Cemma M, Kim PK, Brumell JH. 2011. The ubiquitin-binding adaptor proteins p62/SQSTM1 and NDP52 are recruited independently to bacteria-associated microdomains to target Salmonella to the autophagy pathway. Autophagy 7:341–345. [PubMed]
127. Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI, Youle RJ. 2015. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524:309–314. [PubMed]
128. He C, Klionsky DJ. 2009. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67–93. [PubMed]
129. Huang J, Brumell JH. 2014. Bacteria-autophagy interplay: a battle for survival. Nat Rev Microbiol 12:101–114. [PubMed]
130. Randow F, Youle RJ. 2014. Self and nonself: how autophagy targets mitochondria and bacteria. Cell Host Microbe 15:403–411. [PubMed]
131. Tattoli I, Sorbara MT, Philpott DJ, Girardin SE. 2012. Bacterial autophagy: the trigger, the target and the timing. Autophagy 8:1848–1850. [PubMed]
132. Jia K, Thomas C, Akbar M, Sun Q, Adams-Huet B, Gilpin C, Levine B. 2009. Autophagy genes protect against Salmonella typhimurium infection and mediate insulin signaling-regulated pathogen resistance. Proc Natl Acad Sci U S A 106:14564–14569. [PubMed]
133. Yano T, Mita S, Ohmori H, Oshima Y, Fujimoto Y, Ueda R, Takada H, Goldman WE, Fukase K, Silverman N, Yoshimori T, Kurata S. 2008. Autophagic control of Listeria through intracellular innate immune recognition in Drosophila. Nat Immunol 9:908–916. [PubMed]
134. Campoy E, Colombo MI. 2009. Autophagy in intracellular bacterial infection. Biochim Biophys Acta 1793:1465–1477. [PubMed]
135. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753–766. [PubMed]
136. Van Grol J, Muniz-Feliciano L, Portillo JA, Bonilha VL, Subauste CS. 2013. CD40 induces anti-Toxoplasma gondii activity in nonhematopoietic cells dependent on autophagy proteins. Infect Immun 81:2002–2011. [PubMed]
137. Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A. 2012. A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe 12:334–345. [PubMed]
138. Benjamin JL, Sumpter R, Jr, Levine B, Hooper LV. 2013. Intestinal epithelial autophagy is essential for host defense against invasive bacteria. Cell Host Microbe 13:723–734. [PubMed]
139. Wagner D, Maser J, Lai B, Cai Z, Barry CE, III, Höner Zu Bentrup K, Russell DG, Bermudez LE. 2005. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell’s endosomal system. J Immunol 174:1491–1500. [PubMed]
140. White C, Lee J, Kambe T, Fritsche K, Petris MJ. 2009. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem 284:33949–33956. [PubMed]
141. Nairz M, Schleicher U, Schroll A, Sonnweber T, Theurl I, Ludwiczek S, Talasz H, Brandacher G, Moser PL, Muckenthaler MU, Fang FC, Bogdan C, Weiss G. 2013. Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med 210:855–873. [PubMed]
142. Botella H, Peyron P, Levillain F, Poincloux R, Poquet Y, Brandli I, Wang C, Tailleux L, Tilleul S, Charrière GM, Waddell SJ, Foti M, Lugo-Villarino G, Gao Q, Maridonneau-Parini I, Butcher PD, Castagnoli PR, Gicquel B, de Chastellier C, Neyrolles O. 2011. Mycobacterial P1-type ATPases mediate resistance to zinc poisoning in human macrophages. Cell Host Microbe 10:248–259. [PubMed]
143. Nagase H, Visse R, Murphy G. 2006. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562–573. [PubMed]
144. Ibana JA, Belland RJ, Zea AH, Schust DJ, Nagamatsu T, AbdelRahman YM, Tate DJ, Beatty WL, Aiyar AA, Quayle AJ. 2011. Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells. Infect Immun 79:4425–4437. [PubMed]
145. Pfefferkorn ER. 1984. Interferon γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A 81:908–912. [PubMed]
146. Zhang YJ, Reddy MC, Ioerger TR, Rothchild AC, Dartois V, Schuster BM, Trauner A, Wallis D, Galaviz S, Huttenhower C, Sacchettini JC, Behar SM, Rubin EJ. 2013. Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell 155:1296–1308. [PubMed]
147. Divanovic S, Sawtell NM, Trompette A, Warning JI, Dias A, Cooper AM, Yap GS, Arditi M, Shimada K, Duhadaway JB, Prendergast GC, Basaraba RJ, Mellor AL, Munn DH, Aliberti J, Karp CL. 2012. Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis 205:152–161. [PubMed]
148. Degrandi D, Hoffmann R, Beuter-Gunia C, Pfeffer K. 2009. The proinflammatory cytokine-induced IRG1 protein associates with mitochondria. J Interferon Cytokine Res 29:55–67. [PubMed]
149. Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O, Binz T, Wegner A, Tallam A, Rausell A, Buttini M, Linster CL, Medina E, Balling R, Hiller K. 2013. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci U S A 110:7820–7825. [PubMed]
150. Muñoz-Elías EJ, McKinney JD. 2006. Carbon metabolism of intracellular bacteria. Cell Microbiol 8:10–22. [PubMed]
151. MacMicking JD. 2014. Cell-autonomous effector mechanisms against Mycobacterium tuberculosis. Cold Spring Harb Perspect Med 4:a018507. doi:10.1101/cshperspect.a018507.
152. Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent EE, Loginicheva E, Cervantes-Barragan L, Ma X, Huang SC, Griss T, Weinheimer CJ, Khader S, Randolph GJ, Pearce EJ, Jones RG, Diwan A, Diamond MS, Artyomov MN. 2016. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab 24:158–166. [PubMed]
153. Ganz T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–720. [PubMed]
154. Eisenhauer PB, Lehrer RI. 1992. Mouse neutrophils lack defensins. Infect Immun 60:3446–3447. [PubMed]
155. Wang J, Wong ES, Whitley JC, Li J, Stringer JM, Short KR, Renfree MB, Belov K, Cocks BG. 2011. Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options. PLoS One 6:e24030. doi:10.1371/journal.pone.0024030.
156. Diamond G, Beckloff N, Weinberg A, Kisich KO. 2009. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15:2377–2392. [PubMed]
157. Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250. [PubMed]
158. Dean RE, O’Brien LM, Thwaite JE, Fox MA, Atkins H, Ulaeto DO. 2010. A carpet-based mechanism for direct antimicrobial peptide activity against vaccinia virus membranes. Peptides 31:1966–1972. [PubMed]
159. Sengupta D, Leontiadou H, Mark AE, Marrink SJ. 2008. Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim Biophys Acta 1778:2308–2317. [PubMed]
160. Yeaman MR, Yount NY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27–55. [PubMed]
161. Gunn JS. 2008. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol 16:284–290. [PubMed]
162. Beceiro A, Tomás M, Bou G. 2013. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev 26:185–230. [PubMed]
163. Nakatsuji T, Gallo RL. 2012. Antimicrobial peptides: old molecules with new ideas. J Invest Dermatol 132:887–895. [PubMed]
164. Alonso S, Pethe K, Russell DG, Purdy GE. 2007. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc Natl Acad Sci U S A 104:6031–6036. [PubMed]
165. Hiemstra PS, van den Barselaar MT, Roest M, Nibbering PH, van Furth R. 1999. Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages. J Leukoc Biol 66:423–428. [PubMed]
166. Kim BH, Shenoy AR, Kumar P, Bradfield CJ, MacMicking JD. 2012. IFN-inducible GTPases in host cell defense. Cell Host Microbe 12:432–444. [PubMed]
167. Kim BH, Shenoy AR, Kumar P, Das R, Tiwari S, MacMicking JD. 2011. A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. Science 332:717–721. [PubMed]
168. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC. 2005. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog 1:e24. doi:10.1371/journal.ppat.0010024. [PubMed]
169. Li G, Zhang J, Sun Y, Wang H, Wang Y. 2009. The evolutionarily dynamic IFN-inducible GTPase proteins play conserved immune functions in vertebrates and cephalochordates. Mol Biol Evol 26:1619–1630. [PubMed]
170. Gilly M, Wall R. 1992. The IRG-47 gene is IFN-gamma induced in B cells and encodes a protein with GTP-binding motifs. J Immunol 148:3275–3281. [PubMed]
171. Taylor GA, Jeffers M, Largaespada DA, Jenkins NA, Copeland NG, Vande Woude GF. 1996. Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon γ. J Biol Chem 271:20399–20405. [PubMed]
172. Carlow DA, Marth J, Clark-Lewis I, Teh HS. 1995. Isolation of a gene encoding a developmentally regulated T cell-specific protein with a guanine nucleotide triphosphate-binding motif. J Immunol 154:1724–1734. [PubMed]
173. Sorace JM, Johnson RJ, Howard DL, Drysdale BE. 1995. Identification of an endotoxin and IFN-inducible cDNA: possible identification of a novel protein family. J Leukoc Biol 58:477–484. [PubMed]
174. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Fütterer A, Pfeffer K, Howard JC. 1998. Two families of GTPases dominate the complex cellular response to IFN-γ. J Immunol 161:6715–6723. [PubMed]
175. Shenoy AR, Kim B-H, Choi H-P, Matsuzawa T, Tiwari S, MacMicking JD. 2007. Emerging themes in IFN-γ-induced macrophage immunity by the p47 and p65 GTPase families. Immunobiology 212:771–784. [PubMed]
176. Bekpen C, Hunn JP, Rohde C, Parvanova I, Guethlein L, Dunn DM, Glowalla E, Leptin M, Howard JC. 2005. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol 6:R92. doi:10.1186/gb-2005-6-11-r92.
177. Lilue J, Müller UB, Steinfeldt T, Howard JC. 2013. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse. eLife 2:e01298. doi:10.7554/eLife.01298. [PubMed]
178. Tiwari S, Choi HP, Matsuzawa T, Pypaert M, MacMicking JD. 2009. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P2 and PtdIns(3,4,5)P3 promotes immunity to mycobacteria. Nat Immunol 10:907–917. [PubMed]
179. MacMicking JD. 2004. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 25:601–609. [PubMed]
180. Singh SB, Ornatowski W, Vergne I, Naylor J, Delgado M, Roberts E, Ponpuak M, Master S, Pilli M, White E, Komatsu M, Deretic V. 2010. Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria. Nat Cell Biol 12:1154–1165. [PubMed]
181. Haldar AK, Saka HA, Piro AS, Dunn JD, Henry SC, Taylor GA, Frickel EM, Valdivia RH, Coers J. 2013. IRG and GBP host resistance factors target aberrant, “non-self” vacuoles characterized by the missing of “self” IRGM proteins. PLoS Pathog 9:e1003414. doi:10.1371/journal.ppat.1003414.
182. Steinfeldt T, Könen-Waisman S, Tong L, Pawlowski N, Lamkemeyer T, Sibley LD, Hunn JP, Howard JC. 2010. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol 8:e1000576. doi:10.1371/journal.pbio.1000576.
183. Kim BH, Chee JD, Bradfield CJ, Park ES, Kumar P, MacMicking JD. 2016. Interferon-induced guanylate-binding proteins in inflammasome activation and host defense. Nat Immunol 17:481–489. [PubMed]
184. Shenoy AR, Wellington DA, Kumar P, Kassa H, Booth CJ, Cresswell P, MacMicking JD. 2012. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 336:481–485. [PubMed]
185. Meunier E, Dick MS, Dreier RF, Schürmann N, Kenzelmann Broz D, Warming S, Roose-Girma M, Bumann D, Kayagaki N, Takeda K, Yamamoto M, Broz P. 2014. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature 509:366–370. [PubMed]
186. Finethy R, Jorgensen I, Haldar AK, de Zoete MR, Strowig T, Flavell RA, Yamamoto M, Nagarajan UM, Miao EA, Coers J. 2015. Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages. Infect Immun 83:4740–4749. [PubMed]
187. Pilla DM, Hagar JA, Haldar AK, Mason AK, Degrandi D, Pfeffer K, Ernst RK, Yamamoto M, Miao EA, Coers J. 2014. Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. Proc Natl Acad Sci U S A 111:6046–6051. [PubMed]
188. Man SM, Karki R, Malireddi RK, Neale G, Vogel P, Yamamoto M, Lamkanfi M, Kanneganti TD. 2015. The transcription factor IRF1 and guanylate-binding proteins target activation of the AIM2 inflammasome by Francisella infection. Nat Immunol 16:467–475. [PubMed]
189. Meunier E, Wallet P, Dreier RF, Costanzo S, Anton L, Rühl S, Dussurgey S, Dick MS, Kistner A, Rigard M, Degrandi D, Pfeffer K, Yamamoto M, Henry T, Broz P. 2015. Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida. Nat Immunol 16:476–484. [PubMed]
190. Tyrkalska SD, Candel S, Angosto D, Gómez-Abellán V, Martín-Sánchez F, García-Moreno D, Zapata-Pérez R, Sánchez-Ferrer Á, Sepulcre MP, Pelegrín P, Mulero V. 2016. Neutrophils mediate Salmonella Typhimurium clearance through the GBP4 inflammasome-dependent production of prostaglandins. Nat Commun 7:12077. doi:10.1038/ncomms12077.
191. Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M. 2009. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50:1727–1737. [PubMed]
192. Nordmann A, Wixler L, Boergeling Y, Wixler V, Ludwig S. 2012. A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J 26:1290–1300. [PubMed]
193. Rupper AC, Cardelli JA. 2008. Induction of guanylate binding protein 5 by gamma interferon increases susceptibility to Salmonella enterica serovar Typhimurium-induced pyroptosis in RAW 264.7 cells. Infect Immun 76:2304–2315. [PubMed]
194. Tietzel I, El-Haibi C, Carabeo RA. 2009. Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-γ. PLoS One 4:e6499. doi:10.1371/journal.pone.0006499. [PubMed]
195. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima J, Sasai M, Kayama H, Okamoto T, Huang DCS, Soldati-Favre D, Horie K, Takeda J, Takeda K. 2012. A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37:302–313. [PubMed]
196. Degrandi D, Konermann C, Beuter-Gunia C, Kresse A, Würthner J, Kurig S, Beer S, Pfeffer K. 2007. Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J Immunol 179:7729–7740. [PubMed]
197. Olszewski MA, Gray J, Vestal DJ. 2006. In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. J Interferon Cytokine Res 26:328–352. [PubMed]
198. Degrandi D, Kravets E, Konermann C, Beuter-Gunia C, Klümpers V, Lahme S, Wischmann E, Mausberg AK, Beer-Hammer S, Pfeffer K. 2013. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc Natl Acad Sci U S A 110:294–299. [PubMed]
199. Selleck EM, Fentress SJ, Beatty WL, Degrandi D, Pfeffer K, Virgin HW, IV, Macmicking JD, Sibley LD. 2013. Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog 9:e1003320. doi:10.1371/journal.ppat.1003320. [PubMed]
200. Wehner M, Kunzelmann S, Herrmann C. 2012. The guanine cap of human guanylate-binding protein 1 is responsible for dimerization and self-activation of GTP hydrolysis. FEBS J 279:203–210. [PubMed]
201. Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. 2000. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403:567–571. [PubMed]
202. Kunzelmann S, Praefcke GJK, Herrmann C. 2006. Transient kinetic investigation of GTP hydrolysis catalyzed by interferon-γ-induced hGBP1 (human guanylate binding protein 1). J Biol Chem 281:28627–28635. [PubMed]
203. Syguda A, Bauer M, Benscheid U, Ostler N, Naschberger E, Ince S, Stürzl M, Herrmann C. 2012. Tetramerization of human guanylate-binding protein 1 is mediated by coiled-coil formation of the C-terminal α-helices. FEBS J 279:2544–2554. [PubMed]
204. Wehner M, Herrmann C. 2010. Biochemical properties of the human guanylate binding protein 5 and a tumor-specific truncated splice variant. FEBS J 277:1597–1605. [PubMed]
205. Ghosh A, Praefcke GJK, Renault L, Wittinghofer A, Herrmann C. 2006. How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP. Nature 440:101–104. [PubMed]
206. Abdullah N, Srinivasan B, Modiano N, Cresswell P, Sau AK. 2009. Role of individual domains and identification of internal gap in human guanylate binding protein-1. J Mol Biol 386:690–703. [PubMed]
207. Ohshima J, Sasai M, Liu J, Yamashita K, Ma JS, Lee Y, Bando H, Howard JC, Ebisu S, Hayashi M, Takeda K, Standley DM, Frickel EM, Yamamoto M. 2015. RabGDIα is a negative regulator of interferon-γ-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondii. Proc Natl Acad Sci U S A 112:E4581–E4590. [PubMed]
208. Modiano N, Lu YE, Cresswell P. 2005. Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-γ-inducible cofactor. Proc Natl Acad Sci U S A 102:8680–8685. [PubMed]
209. Britzen-Laurent N, Bauer M, Berton V, Fischer N, Syguda A, Reipschläger S, Naschberger E, Herrmann C, Stürzl M. 2010. Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner. PLoS One 5:e14246. doi:10.1371/journal.pone.0014246.
210. Kravets E, Degrandi D, Weidtkamp-Peters S, Ries B, Konermann C, Felekyan S, Dargazanli JM, Praefcke GJ, Seidel CA, Schmitt L, Smits SH, Pfeffer K. 2012. The GTPase activity of murine guanylate-binding protein 2 (mGBP2) controls the intracellular localization and recruitment to the parasitophorous vacuole of Toxoplasma gondii. J Biol Chem 287:27452–27466. [PubMed]
211. Krapp C, Hotter D, Gawanbacht A, McLaren PJ, Kluge SF, Stürzel CM, Mack K, Reith E, Engelhart S, Ciuffi A, Hornung V, Sauter D, Telenti A, Kirchhoff F. 2016. Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity. Cell Host Microbe 19:504–514. [PubMed]
212. Fres JM, Müller S, Praefcke GJ. 2010. Purification of the CaaX-modified, dynamin-related large GTPase hGBP1 by coexpression with farnesyltransferase. J Lipid Res 51:2454–2459. [PubMed]
213. Virreira Winter S, Niedelman W, Jensen KD, Rosowski EE, Julien L, Spooner E, Caradonna K, Burleigh BA, Saeij JPJ, Ploegh HL, Frickel EM. 2011. Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it. PLoS One 6:e24434. doi:10.1371/journal.pone.0024434.
214. Horisberger MA, Staeheli P, Haller O. 1983. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci U S A 80:1910–1914. [PubMed]
215. Pendin D, Tosetto J, Moss TJ, Andreazza C, Moro S, McNew JA, Daga A. 2011. GTP-dependent packing of a three-helix bundle is required for atlastin-mediated fusion. Proc Natl Acad Sci U S A 108:16283–16288. [PubMed]
216. Schulte K, Pawlowski N, Faelber K, Fröhlich C, Howard J, Daumke O. 2016. The immunity-related GTPase Irga6 dimerizes in a parallel head-to-head fashion. BMC Biol 14:14. doi:10.1186/s12915-016-0236-7. [PubMed]
217. Haller O, Staeheli P, Schwemmle M, Kochs G. 2015. Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol 23:154–163. [PubMed]
218. Mitchell PS, Young JM, Emerman M, Malik HS. 2015. Evolutionary analyses suggest a function of MxB immunity proteins beyond lentivirus restriction. PLoS Pathog 11:e1005304. doi:10.1371/journal.ppat.1005304.
219. Haller O, Staeheli P, Kochs G. 2007. Interferon-induced Mx proteins in antiviral host defense. Biochimie 89:812–818. [PubMed]
220. Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD. 2013. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502:563–566. [PubMed]
221. Goujon C, Moncorgé O, Bauby H, Doyle T, Ward CC, Schaller T, Hué S, Barclay WS, Schulz R, Malim MH. 2013. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502:559–562. [PubMed]
222. Braun BA, Marcovitz A, Camp JG, Jia R, Bejerano G. 2015. Mx1 and Mx2 key antiviral proteins are surprisingly lost in toothed whales. Proc Natl Acad Sci U S A 112:8036–8040. [PubMed]
microbiolspec.MCHD-0050-2016.citations
cm/4/6
content/journal/microbiolspec/10.1128/microbiolspec.MCHD-0050-2016
Loading

Citations loading...

Loading

Article metrics loading...

/content/journal/microbiolspec/10.1128/microbiolspec.MCHD-0050-2016
2016-12-16
2017-09-21

Abstract:

Specialized adaptations for killing microbes are synonymous with phagocytic cells including macrophages, monocytes, inflammatory neutrophils, and eosinophils. Recent genome sequencing of extant species, however, reveals that analogous antimicrobial machineries exist in certain non-immune cells and also within species that ostensibly lack a well-defined immune system. Here we probe the evolutionary record for clues about the ancient and diverse phylogenetic origins of macrophage killing mechanisms and how some of their properties are shared with cells outside the traditional bounds of immunity in higher vertebrates such as mammals.

Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Evolution of antimicrobial effector mechanisms. Depicted is a phylogenetic tree of the unikonts ( and ) and a summary of accompanying cell-autonomous effector mechanisms common to each major group. Scale indicates divergent nodal distance across NCBI taxa. Phylogram generated in Dendroscope 3.

Source: microbiolspec December 2016 vol. 4 no. 6 doi:10.1128/microbiolspec.MCHD-0050-2016
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Canonical effector mechanisms in myeloid cells. (A) Enzymatically derived metabolites are potent antimicrobials. Macrophages deploy nutriprive mechanisms to reduce accessible nutrients and inhibit microbial growth, including NRAMP1 (SLC11A1), which pumps iron out of the phagosome; and IFN-γ-induced IDO1, which degrades intracellular tryptophan into kynurenine metabolites, which in themselves can be toxic to microbes. Superoxide generation by NOX2 and possibly DUOX1/2 generate ROS on the luminal side of the phagosome, which is directly antimicrobial. NO generation by NOS is also cytotoxic. Acidification by lysosomal V-ATPases or import of copper/zinc ions also functions to create a bactericidal environment within the phagosome. (B) AMPs are generated within the Golgi and trafficked to the pathogen-containing endosome. Here, they are processed into their active form to induce bacterial lysis. (C) Intracellular pathogens, either vacuolar or cytosolic, can become targeted by the autophagic machinery via host adaptor proteins that recognize signals of microbial infection. Proposed mechanisms include adaptors like p62/SQSTM1, which bind to ubiquitinated microbes or vacuoles; lectins like galectin 8 (LGALS8), which bind glycans exposed on damaged vacuoles; and TRIM21, which binds antibodies on the surface of incoming bacteria and viruses. These adaptors promote phagophore formation around their cargo by binding to autophagosome adaptor LC3. Microbes are then sequestered within the autophagosome, a process that requires the ATG proteins, and fuse with the lysosome for degradation.

Source: microbiolspec December 2016 vol. 4 no. 6 doi:10.1128/microbiolspec.MCHD-0050-2016
Permissions and Reprints Request Permissions
Download as Powerpoint

Supplemental Material

No supplementary material available for this content.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error